• Explore /
  • Poster
  • / Alliance A032002 (ART): Phase II randomized trial of atezolizumab versus atezolizumab and radiation therapy for platinum-ineligible/refractory metastatic urothelial cancer.

Alliance A032002 (ART): Phase II randomized trial of atezolizumab versus atezolizumab and radiation therapy for platinum-ineligible/refractory metastatic urothelial cancer.

Abstract Poster

Authors

Himanshu Nagar

Himanshu Nagar

Weill Cornell Medicine, New York, NY

Himanshu Nagar , Karla V. Ballman , Scott T. Tagawa , Alan Tan , Bishoy Morris Faltas , Arshin Sheybani , Shiva Baghaie , Lawrence Howard Schwartz , David E. Kozono , Jeffrey A Bogart , Olivia Conway , Ronald C. Chen , Andrew Leonard Laccetti , Jonathan E. Rosenberg , Michael J. Morris , Gina L. Mazza

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Urothelial Carcinoma

Track

Urothelial Carcinoma

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04936230

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr TPS589)

DOI

10.1200/JCO.2023.41.6_suppl.TPS589

Abstract #

TPS589

Poster Bd #

P12

Abstract Disclosures

Similar Posters

First Author: Haojie Li

First Author: Guru Sonpavde

First Author: Alfonso Gomez De Liano Lista

First Author: Nataliya Mar